Delivery Order SPE2DB24D2205-SPE2DB25FEGJB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a contract value of $4,568.72. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,262.48 for Mounjaro 5 mg/0.5 mL pen injectors on August 27, 2025, with an ultimate completion date of August 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,162.70 for Mounjaro 7.5 mg/0.5 ml pen auto-injectors on July 23, 2025, with completion targeted for July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, representing part of the company's...
- The Defense Logistics Agency awarded a $21,011.11 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The order will be fulfilled from the company's facility in...
- The Defense Logistics Agency awarded a $33,391.18 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,057.94 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes treatment medication, consistent with AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a $1,904.63 delivery order contract to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors with a completion date of August 19, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing as the pricing mechanism. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $14,094.91 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Mounjaro is a diabetes management medication, consistent with AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.10 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors on July 30, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used for diabetes management, consistent with the...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGJBDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,548.95 for Mounjaro 7.5 mg/0.5 mL pen injectors on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Mounjaro is a diabetes medication supplied through this contract to support federal medical procurement needs, particularly for military and veteran healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains extensive experience fulfilling federal medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The parent IDC demonstrates the contractor's capability to deliver a diverse pharmaceutical portfolio to support Defense Health Agency operations and other government healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.5k | 8/15/25 |